AC-1202 rapidly and safely improved cognition and short term memory BROOMFIELD, Colo., Aug. 12 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) disorders, announced today... (Source: Drugs.com - Clinical Trials)

Read the original Alzheimer's Group Resources article at MedWorm: Alzheimer's ...

Tags: , , ,

Leave your comment


SEO Powered by Platinum SEO from Techblissonline